Page last updated: 2024-09-02

ecteinascidin 743 and ridaforolimus

ecteinascidin 743 has been researched along with ridaforolimus in 1 studies

Compound Research Comparison

Studies (ecteinascidin 743)	Trials (ecteinascidin 743)	Recent Studies (post-2010) (ecteinascidin 743)	Studies (ridaforolimus)	Trials (ridaforolimus)	Recent Studies (post-2010) (ridaforolimus)
660	102	404	112	41	80

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
von Mehren, M	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and ridaforolimus

Article	Year
New therapeutics for soft-tissue sarcomas in adults. Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:1 Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Dioxoles; Enzyme Inhibitors; Humans; Protein Kinases; Protein-Tyrosine Kinases; Sarcoma; Sirolimus; Tetrahydroisoquinolines; Thalidomide; TOR Serine-Threonine Kinases; Trabectedin; Vascular Endothelial Growth Factor A	2007

Article

Year

New therapeutics for soft-tissue sarcomas in adults.

Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:1

Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Dioxoles; Enzyme Inhibitors; Humans; Protein Kinases; Protein-Tyrosine Kinases; Sarcoma; Sirolimus; Tetrahydroisoquinolines; Thalidomide; TOR Serine-Threonine Kinases; Trabectedin; Vascular Endothelial Growth Factor A

2007